All about net worth of Shkreli. Inspiring story

Martin Shkreli Net Worth (Quickly boosted)

Martin Shkreli is one of the richest CEO’s right now. With more than $100 Million net worth, he is having investments in multiple organizations and projects, of which, majority are success. He is having specialty in business related to health care and that’s why he is more concerned and committed to invest in medical related businesses.

  • Martin Shkreli Net Worth: $100,000,000
  • Shkreli annual average income: $40 million ↑↑
  • Sued money: $65,000,000 USD
  • HIV medicine profit: 60% ⇑

More details about Martin Shkreli wealth

There are many organizations which are being founded by him and/or are currently governed by him, which are, but not limited to, MSMB Capital Management, Turing Pharmaceuticals AG and Retrophin LLC.

All about net worth of Shkreli. Inspiring story
I’ll say without his entrepreneur skill he will not be that big earning ($40 million) hedge fund manager

I do not rate him much higher and there are several reasons for my stance. He is more concerned with his popularity and fame, hence not giving much towards the research processes. In the year 2014, he was sued for a reported amount of $65 Million because he misused the precious funds of the company and was also fired from it.

According to a research and survey, he was named as biotech’s one of the worst CEO’s to ever live and reason is in front of you, he is concerned mostly for his own personality. His main competitors is Ma’am Elizabeth Holmes ($3.4 Billion worth Lady). Look at this Shkreli money chart:

chart show Shkreli earning including fund raised amount
Simple chart about Shkreli money

Recently, he has also been accused of increasing the price of a drug related to HIV aids as it is not affordable for a common person right now. It was previously available of an estimated price of $13.50 but is now at $750 approximately per pill which also made clear difference on Martin Shkreli net worth. But changing price increased a lot of hate factor against him, some organizations have also shared a notice with him but it is of no purpose now as he is the owner of that drug.

Video about changing drug price:

Useful resources:

  • http://www.fiercebiotech.com/story/shkrelis-turing-pharma-banks-90m-murky-funding-round/2015-08-10
  • http://www.huffingtonpost.com/dr-mariappan-jawaharlal/tale-of-two-ceos-elizabeth-holmes-martin-shkreli_b_8197094.html
  • http://www.fullnetworth.com/martin-shkreli-net-worth/
  • Image from: http://readnlove.com/martin-shkreli-the-pharmaceutical-horrors/
  • http://www.biospace.com/News/ex-retrophin-ceo-sold-stock-while-urging-investors/356208